1. Kim HB, Kim EW, Lee JB. Superior limbic keratoconjunctivitis. J Korean Ophthalmol Soc. 1981. 22:395–398.
2. Nelson JD. Superior limbic keratoconjunctivitis. Eye. 1989. 3:180–189.
3. Cher I. Blink-related microtrauma: when the ocular surface harms itself. Clin Experiment Ophthalmol. 2003. 31:183–190.
4. Morax S, Touitou V. Complications of blepharoplasty. Orbit. 2006. 25:303–318.
5. Kim JT, Kim JH, Kim JC. Visualization of subconjunctival lymphatics and its significance. J Korean Ophthalmol Soc. 2008. 49:1215–1219.
6. Singh D. Conjunctival lymphatic system. J Cataract Refract Surg. 2003. 29:632–633.
7. Spector JA, Zide BM. Carbon dioxide laser ablation for treatment of lymphangioma of the conjunctiva. Plast Reconstr Surg. 2006. 117:609–612.
8. Wiegand S, Eivazi B, Barth PJ, et al. Pathogenesis of lymphangiomas. Virchows Arch. 2008. 453:1–8.
9. Theodore FH, Ferry AP. Superior limbic keratoconjunctivitis: clinical and pathological correlations. Arch Ophthalmol. 1970. 84:481–484.
10. Cher I. Superior limbic keratoconjunctivitis: multifactorial mechanical pathogenesis. Clin Experiment Ophthalmol. 2000. 28:181–184.
11. Sheu MC, Schoenfield L, Jeng BH. Development of superior limbic keratoconjunctivitis after upper eyelid blepharoplasty surgery:support for the mechanical theory of its pathogenesis. Cornea. 2007. 26:490–492.
12. Ohashi Y, Watanabe H, Kinoshita S, et al. Vitamin A eyedrops for superior limbic keratoconjunctivitis. Am J Ophthalmol. 1988. 105:523–527.
13. Shen YC, Wang CY, Tsai HY, Lee YF. Supratarsal triamcinolone injection in the treatment of superior limbic keratoconjunctivitis. Cornea. 2007. 26:423–426.
14. Duke-Elder S. System of Ophthalmology. 1961. Vol. II & VIII. St. Louis: CV Mosby;541–550. 1965;39-46.
15. Joo JH, Ko MK, Park MH. Ultrastructural and immunofluorescent features of lymphatic disorders in conjunctiva. J Korean Ophthalmol Soc. 1987. 28:545–550.